Antimicrobial resistance poses a significant threat to global public health, driving the search for innovative solutions. Antimicrobial Peptides (AMPs) have emerged as a promising alternative to traditional antibiotics, offering a multifaceted approach to combat various pathogens. This article explores the multifaceted role of AMPs in tackling infectious diseases, their mechanisms of action and their potential as next-generation therapeutic reagents. We discuss the current challenges in AMP development and the key prospects in this field, shedding light on their clinical applications and future potential.
HTML PDFShare this article
Journal of Antimicrobial Agents received 444 citations as per Google Scholar report
